contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

April 1st - June 30th Net sales amounted to SEK 0.5 million (0.4), a revenue growth of 25 percent Earnings before interest and taxes (EBIT) amounted to SEK -5.8 million (-6.3) Earnings per share...

<hl2>April 1st - June 30th</hl2><ul><li> Net sales amounted to SEK 0.5 million (0.4), a revenue growth of 25 percent</li><li> Earnings before interest and taxes (EBIT) amounted to SEK -5.8 million (-6.3)</li><li> Earnings per share after dilution at SEK -0.10 (-0.11)</li><li> Cash flow from operating activities amounted to SEK -6.3 million (-4.9)</li><li> Liquid assets at the end of the period at SEK 8.3 million (34.5)</li><li> Equity ratio was 82 percent (86)</li></ul><hl2>January 1st - June 30th</hl2><ul><li>Net sales amounted to SEK 0.7 million (0.5), a revenue growth of 38 percent</li><li>Earnings before interest and taxes (EBIT) amounted to SEK -11.6 million (-11.1)</li><li>Earnings per share after dilution at SEK -0.20 (-0.19)</li><li>Cash flow from operating activities amounted to SEK -11.8 million (-10.8)</li><li>Liquid assets at the end of the period at SEK 8.3 million (34.5)</li><li>Equity ratio was 82 percent (86)</li></ul><hl2>Summary of events during second quarter </hl2><ul><li> ChloraSolv receives CE marking and is cleared for commercial launch in EU</li><li> RLS Global AB has reached a settlement with Dr. Karin Bergqvist</li><li> During June 5-7, the EWMA Conference (European Wound Management Association) took place in Gothenburg</li><li> The clinical trial in Sweden on ChloraSolv 01 is running according to plan</li><li> ChloraSolv registration for Australia initiated</li></ul><hl2>Summary of events after second quarter</hl2><ul><li> A product specialist joined in August and will drive the ChloraSolv commercialization process for the Swedish market</li><li> Meetings with several Key Opinion Leaders to introduce the benefits of ChloraSolv</li><li> Continuous negotiations with potential global partners</li><li> Extra General Meeting will be held August 19th </li></ul>Trading place and certified advisor  RLS Global's shares has been listed on the Nasdaq First North since 17th May, 2017 and trading takes place under the short name RLS. Certified Adviser is Erik Penser Bank, telephone +46 8 463 83 00, Email: <virtloc>certifiedadviser@penser.se. </virtloc>During the period 2012 - 2017, the company was listed on Aktietorget.Contact information  Karin Fischer, CEO E-mail: <virtloc>karin.fischer@rlsglobal.se </virtloc> Telephone: +46 702 48 46 51Eva Jagenheim, CFO E-mail: <virtloc>eva.jagenheim@rlsglobal.se</virtloc> Telephone: +46 31 780 68 20The interim report is enclosed and is also available at www.rls.globalPublication  RLS Global AB (publ) is obliged to make the information contained herein public pursuant to the EU market abuse regulation. The information was submitted for publication through the agency of the above contact person, at CET 08:30 on August 15th, 2019.